# Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia

> **NCT03254186** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Tardive Dyskinesia

## Interventions

- **DRUG:** Propranolol Hydrochloride
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03254186
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-09-18
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03254186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03254186, "Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03254186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*